Ruffini, Nicolas; Altahini, Saleh; Weissbach, Stephan et al.
ViNe-Seg: deep-learning-assisted segmentation of visible neurons and subsequent analysis embedded in a graphical user interfaceBIOINFORMATICS. Bd. 40. H. 4. 2024
Gao, Zhenling; Dremova, Olga; Karwot, Cornelia et al.
Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital MicroscopyJOVE-JOURNAL OF VISUALIZED EXPERIMENTS. H. 211. 2024
Naveja, JJ; Saldivar-Gonzalez, F; Prado-Romero, D. L. et al.
Visualization, Exploration, and Screening of Chemical Space in Drug DiscoveryVasanthanathan Poongavanam, Vijayan Ramaswamy (Hrsg). Computational Drug Discovery: Methods and Applications. Wiley Online Library 2024
Muetze, Ulrike; Gleich, Florian; Haas, Dorothea et al.
Vitamin B<sub>12</sub> Deficiency Newborn ScreeningPEDIATRICS. Bd. 154. H. 2. 2024
Hannibal, Luciana; Lederer, Ann-Kathrin; Storz, Maximilian A. et al.
Vitamin B<sub>12</sub> Status and Supplementation in Plant-Based DietsFOOD AND NUTRITION BULLETIN. Bd. 45. H. 1_SUPPL. 2024 S. S58-S66
Lammle, Bernhard; Laemmle, Alexander
Vitamin B12 deficiency misdiagnosed as TTP: What can we learn from it?BRITISH JOURNAL OF HAEMATOLOGY. Bd. 205. H. 4. 2024 S. 1255-1256
Mamilos, A.; Maier, G.; Alsofy, Z. et al.
VITAMIN D DEFICIENCY IN ORTHOPEDIC PATIENTS IN DIFFERENT LATITUDES. COMPARING GERMAN AND GREEK POPULATIONSAGING CLINICAL AND EXPERIMENTAL RESEARCH. Bd. 36. 2024 S. S202-S203
Boehm, Markus; Sommer, Rachel; Gieler, Uwe et al.
Vitiligo - a disease: A position paper on stigmatization, life quality impairment and psychosocial comorbidityJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 22. H. 10. 2024 S. 1327-1335
Boehm, Markus; Sommer, Rachel; Gieler, Uwe et al.
Vitiligo - a disease: A position paper on stigmatization, life quality impairment and psychosocial comorbidityJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 22. H. 10. 2024 S. 1335-1336
DelBello, Melissa P.; Findling, Robert L.; Huss, Michael et al.
Vortioxetine in children and adolescents with major depressive disorder: 6-month and 18-month open-label, flexible-dose, long-term extension studiesEUROPEAN CHILD & ADOLESCENT PSYCHIATRY. Bd. 34. H. 4. 2024 S. 1425-1434